Adapting to Change: Federal Policy Dynamics and the Pharmaceutical Industry

The US pharmaceutical landscape is in the midst of impactful shifts.A series of ambitious, aggressive, and often interconnected federal policy changes-from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches-is creating a new reality for industry leaders, innovators, and strategists.In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered. Key Features•Understand the Interconnectedness of U.S.Federal Policies. •Analyze the Strategic Impacts of Key Legislation and Executive Actions. •Evaluate Challenges and Opportunities in a Dynamic Regulatory Environment. •Analyze the Interplay of U.S. Federal Actions and Industry Operations. •Formulate Adaptive Strategies for Industry Resilience.